Tofacitinib, a novel JAK3 inhibitor, as a potential cause of distal symmetric polyneuropathy

J Eur Acad Dermatol Venereol. 2016 Jun;30(6):1066-7. doi: 10.1111/jdv.13114. Epub 2015 Mar 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Humans
  • Male
  • Piperidines / therapeutic use*
  • Psoriasis / drug therapy*
  • Pyrimidines / therapeutic use*
  • Pyrroles / therapeutic use*

Substances

  • Piperidines
  • Pyrimidines
  • Pyrroles
  • tofacitinib